On May 18th, the signing ceremony of the strategic cooperation framework agreement between Luye Life Sciences Group and Binzhou Medical University (BMU) was held in the conference room on the 2nd floor, No.35 Building, Shandong International Biotechnology Park. Zhao Shengtian, President of BMU, delivered a speech, and Wang Guangcheng, Vice President, signed the cooperation agreement with Luye Life Sciences Group on BMU’s behalf. Liu Dianbo, Chairman of Luye Group and Tan Keliang, Director of Yantai Market Supervision and Administration attended the signing ceremony and delivered speeches. Relevant responsible officials from BMU’s Science and Technology Department, Education Department, Yantai Affiliated Hospital of BMU (Second School of Clinical Medicine), School of Basic Medical Sciences, School of Pharmacy (Wine School), School of Rehabilitation Medicine and Medical Research Center, from relevant departments of Yantai Market Supervision Administration and from affiliated units of Luye Life Science Group attended the ceremony.
The Scene of the Meeting
President Zhao Shengtian Delivering a Speech.
In his speech, Zhao Shengtian affectionately recalled the glorious history of mutual support and cooperation between Luye Life Science Group and BMU in the past years to build a development pattern of industry-university-research integration. He pointed out that signing the strategic cooperation framework agreement is one of the important measures for implementing the strategic deployment for deepened industry-education integration, closely coordinating with the major projects of Transition to New from Old Economic Engines of Shandong Provincial Party Committee and Shandong Provincial Government, and pushing forward the “Ten Strong Industries” and “Eight Major Strategies”. It is also the urgent request for BMU’s supply side structural reform of talent nurturing and that of the industrial demand side structural reform. Our cooperation will serve as a strong support for connecting the education and human resources with science and technology, innovation and industry, and will provide further important opportunities and inject strong momentum for the two side to complement with each other’s need, share resources and mutual benefit, and create a win-win situation. He hopes that both sides take this as an opportunity to further strengthen cooperation in collaborative innovation, production-university-research-application, cooperative talent cultivation, and co-sharing and co-construction in many other fields, promote both sides to achieve a higher quality, more efficient and more sustainable development, set up cooperative brand-names of life science with core competitiveness, social contribution, international and domestic influence and lasting vitality, and make new and greater contributions to building a “Healthy China” and serving local economic and social development.
Liu Dianbo, Chairman of Luye Life Science Group Delivering a Speech
Liu Dianbo pointed out in his speech that Luye Life Science Group and BMU share the same vision and have a long history of cooperation. After years of innovation accumulation, Luye Life Science Group has achieved remarkable innovation achievements. In addition to a number of innovation achievements that have been on or will be on market soon, Luye Life Science Group has also established a number of technology platforms with core competitiveness, including the State Key Laboratory of Long-Acting and Targeted Preparations, whole human antibody transgenic mice research, VLP virus particle technology, etc. BMU enjoys profound foundation and outstanding advantages in medical discipline construction, basic medical research and clinical medical research. This cooperation is a common choice by both Luye Life Science Group and BMU for innovation and development. Both sides will give full play to their advantages in transformation of scientific research resources and innovation achievements application to make joint efforts in building development platform, breaking the barrier between drug development and clinical requirements and that between basic scientific research and clinical transformation. We will promote deeper integration of industries, universities and research institutes, and help universities and enterprises develop in a higher quality, more efficient and more sustainable way.
Tan Keliang, Director of Yantai Market Supervision Administration Delivering a Speech
Tan Keliang pointed out that the biomedical industry is an advanced industry, that Yantai attaches importance to, and has been successfully included in the first batch of strategic emerging industrial clusters in China and one of the first “Top Ten” industries in Shandong Province. CPC Yantai Municipal Committee and Yantai Munincipal Government strongly supports the innovation priority and breakthrough to the development of the biomedical industry. In this way, the city's biomedical industry has entered a new stage of high-quality development. He stressed that Binzhou Medical University and Luye Life Science Group, by signing a strategic cooperation agreement, jointly building innovation system, strengthening talent training, deepening project cooperation, accelerating the transformation and application of scientific and technological achievements, marked a new stage of close cooperation and common development between the two sides, and has far-reaching strategic significance. He hoped that the two sides, standing at a new historical starting point, will cooperate sincerely, ride the wind and waves, win the future, and provide new driving force to the high-quality development of Yantai’s biomedical industry.
The Scene of the Signing Ceremony
After the signing ceremony, the two sides held a face-to-face discussion, with relevant departments carrying out in-depth exchanges and discussions on the specific issues of the cooperation agreement and putting forward valuable suggestions on next steps to implement the agreement.
According to the agreement, and Luye Life Science and BMU will give full play to the health, medicine, teaching, research, production and other advantages of resources, carry out collaborative innovation, industry-university-research-application, cooperation in co-cultivation, and joint construction shared by all. The two sides will strengthen cooperation in innovation system/platform, innovative talent training and development, enhanced scientific and technological cooperation and academic exchanges, accelerate the transformation of scientific and technological achievements application, work together to enhance the technological innovation capacity, talent introduction and education capacity and achievement transformation capacity of both sides, promote the mutual connection, two-way force and all-round integration of the two sides, and jointly create a model of university-enterprise cooperation in exploration and innovation.
SOURCE: News Center
BY: Gao Sen
